Clinical Trial Update: Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated infliximab, sirolimus, and daclizumab for age-related macular degeneration, with results posted after completion in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Daclizumab (daclizumab)
• Infliximab (infliximab)
• Sirolimus (Sirolimus)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Age-Related Macular Degeneration, Choroidal Neovascularization | Phase 2 | Status: COMPLETED | Results posted: 2011-04-12